Filling the need for trusted information on national health issues

Pharma Companies Need Better Incentives, Innovation To Invest In Neglected Diseases Pharma firms pressed to tackle neglected diseases in developing world
“Poverty-related and neglected diseases (PRNDs) disproportionately affect the world’s poorest populations. Better incentives are needed for pharmaceutical companies to develop drugs, health campaigners say. Europe plays a critical role in developing new PRND products that are saving millions of lives and millions of euros in the world’s poorest countries…” (Jacobsen, 3/11).